DESIGN AND DEVELOPMENT OF ANTI-INFLAMMATORY DRUG NAPROXEN SOLID DISPERSIONS AND FORMULATIONS BY FACTORIAL DESIGN APPROACH

Naproxen Solid Dispersions and Formulations

Authors

  • Taraka Ramarao Challa Department of Pharmaceutical Technology, Sri Venkateswara College of Pharmacy, Etchrela, Srikakulam, Andhra Pradesh https://orcid.org/0000-0001-7918-8808
  • Pathivada SaiKiranmai

DOI:

https://doi.org/10.55766/sujst-2023-06-e01216

Keywords:

Design Expert, In Vitro, Naprosy, Naproxen, Solid Dispersion

Abstract

Naproxen is a non-steroidal anti-inflammatory (NSAID) drug that can be used as an analgesic, anti-inflammatory, and antipyretic. Objectives: The study’s major goal was to improve the drug’s solubility and dissolution rate, as well as its oral bioavailability. Methods: Physical mixture, kneading process, and solvent evaporation method were used to make Naproxen solid dispersions (SDs). Using a two-level factorial design and three independent components, X1 β-Cyclodextrin, X2: Kolliphor p-188, and X3: PVPK-30 and designed by a Design expert (DOE). The formulation was studied by flow parameters, physical characteristics, Fourier-transform infrared spectroscopy, and comparative investigations with commercially available Naprosyn and F2. Major Results: In vitro performance of solid dispersions SD’s was favorable (100% drug release 20 minutes), compared to a pure drug, where 100 percent drug release takes 80 minutes. The FTIR spectra of pure drug and combinations with excipients were having no chemical interaction. The F44<F88<F77<F11<F66<F55<F33<F2 depicts the order of released various formulations. The release profiles of F2 and the Naprosyn tablet are similar. These findings suggest that a new naproxen tablet formulation, including the β-Cyclodextrin: Kolliphor - p188 complex, could be a viable alternative for improving oral bioavailability.

References

Abou-Okeil, A., Rehan, M., El-Sawy, S.M., El-bisi, M.K., Ahmed-Farid, O.A., and Abdel-Mohdy, F.A. (2018). Lidocaine/β-cyclodextrin inclusion complex as drug delivery system. European Polymer Journal, 108:304-310. https://doi.org/10.1016/j.eurpolymj.2018.09.016

Arumugam, S.P., Suganya, B.B., Vigneshkumar, G., Maniyazagan, M., Sakthi, V.K., Vimalasruthi, N., Vaseeharan, B., Sivakamavalli, J., and Stalin, T. (2019). In-vitro dissolution and microbial inhibition studies on anticancer drug etoposide with β-cyclodextrin. Materials Science and Engineering: C, 102:96-105. https://doi.org/10.1016/j.msec.2019.04.033

Aydar, A.Y. (2018). Utilization of response surface methodology in optimization of extraction of plant materials. Statistical Approaches With Emphasis on Design of Experiments Applied to Chemical Processes, https://doi.org/10.5772/intechopen.73690

Bhavyasri, K. and Taraka Ramarao, CH. (2018). Formulation and Evaluation of Zidovudine Floating Tablets. World Journal of Pharmacy and Pharmaceutical Sciences, 7(8):1,210-1,220.

Brandes, J.L., Kudrow, D., Stark, S.R., O’Carroll, C.P., Adelman, J.U., O’Donnell, F.J., Alexander, W.J., Spruill, S.E., Barrett, P.S., and Lener, S.E. (2007). Sumatriptan-naproxen for acute treatment of Migraine. Journal of the American Medical Association, 297(13):1,443-1,454. https://doi.org/10.1001/jama.297.13.1443

Ch, T. and Chowdary, K.P.R. (2016). Formulation development of valsartan tablets: optimization by 23factorial design, in vitro and pharmacokinetic evaluation. World Journal of Pharmaceutical Research, 5(2):1,423-1,434.

Ch, T. and Jami, R. (2022). Formulation development of Ezetimibe by using Soluplus and Co-processed Acacia: tragacanth with Design Expert. Health Biotechnology and Biopharma (HBB), 6(3):33-56.

Challa, T.R. and Reshma, K. (2022). Experimental Design Statistically by Design Expert Software: A Model Poorly Soluble Drug with Dissolution Enhancement and Optimization. International Journal of Drug Delivery Technology, 12(3):1,367-1,375. https://doi.org/10.25258/ijddt.12.3.72

Chenguang, W., Sujay, A.C., Yiwang, G., Julia, T.E., Boxin, T., En, W., Marc, A.H., Timothy, P.L, and Changquan C.S. (2018). Preparation, Characterization, and Formulation Development of Drug-Drug Protic Ionic Liquids of Diphenhydramine with Ibuprofen and Naproxen. Molecular Pharmaceutics, 15(9):4,190-4,201. https://doi.org/10.1021/acs.molpharmaceut.8b00569

Chowdary, K.P.R. and Rao, C.H.T. (2011). Factorial Study on the Evaluation of Formulation Variables on the Dissolution Rate of EtoricoxibTablets. Asian Journal of Chemistry, 23(3):958-960.

Chowdary, K.PR. and Rajeswararao, P. (2015). Pharmacokinetic Evaluation of Optimized Valsartan Tablets Formulated Employing βCD, Crospovidone and SLS in Comparison to a Marketproduct. World journal of pharmacy and pharmaceutical sciences, 4(9):979-986.

Cova, T.F., Murtinho, D., Pais, A.A., and Valente, A.J. (2018). Combining cellulose and cyclodextrins:Fascinating designs for materials and Pharmaceutics. Frontiers in Chemistry, 05. https://doi.org/10.3389/fchem.2018.00271

Deshkar, S.S. and Palve, V.K. (2019). Formulation and development of thermosensitive cyclodextrin-based in situ gel of voriconazole for vaginal delivery. Journal of Drug Delivery Science and Technology, 49:277-285. https://doi.org/10.1016/j.jddst.2018.11.023

Dong, W., Su, X., Xu, M., Hu, M., Sun, Y., and Zhang, P. (2018). Preparation, characterization, and in vitro/vivo evaluation of polymer-assisting formulation of atorvastatin calcium based on solid dispersion technique. Asian Journal of Pharmaceutical Sciences, 13(6):546-554. https://doi.org/10.1016/j.ajps.2018.08.010

Dou, S., Ouyang, Q., You, K., Qian, J., and Tao, N. (2018). An inclusion complex of thymol into β-cyclodextrin and its antifungal activity against Geotrichumcitri-aurantii. Postharvest Biology and Technology, 138:31-36. https://doi.org/10.1016/j.postharvbio.2017.12.011

Dun, J., Osei-Yeboah, F., Boulas, P., Lin, Y., and Sun, C.C. (2020). A systematic evaluation of poloxamers as tablet lubricants. International Journal of Pharmaceutics, 576:118994. https://doi.org/10.1016/j.ijpharm.2019.118994

Durakovic, B. (2017). Design of experiments application, concepts, examples: State of the art. Periodicals of Engineering and Natural Sciences (PEN), 5(3). https://doi.org/10.21533/pen.v5i3.145

Fathalla, Z.M.A., Vangala, A., Longman, M., Khaled, K.A., Hussein, A.K., El-Garhy, O.H., and Alany, R.G. (2017). Poloxamer-based thermoresponsive Ketorolac tromethamine in situ gel preparations: Design, characterisation, toxicity and trans corneal permeation studies. European Journal of Pharmaceutics and Biopharmaceutics, 114:119-134. https://doi.org/10.1016/j.ejpb.2017.01.008

Fukuda, I.M., Pinto, C.F., Moreira, C. dos, Saviano, A.M., and Lourenço, F.R. (2018). Design of experiments (DOE) applied to pharmaceutical and analytical quality by design (QBD). Brazilian Journal of Pharmaceutical Sciences, 54(spe). https://doi.org/10.1590/s2175-97902018000001006

Furlanetto, S., Cirri, M., Maestrelli, F., Corti, G., and Mura, P. (2006). Study of formulation variables influencing the drug release rate from matrix tablets by experimental design. European Journal of Pharmaceutics and Biopharmaceutics, 62(1):77-84. https://doi.org/10.1016/j.ejpb.2005.07.001

Gidwani, B. and Vyas, A. (2015). A comprehensive review on Cyclodextrin-based carriers for delivery of chemotherapeutic cytotoxic anticancer drugs. BioMedResearch International, 1-15. https://doi.org/10.1155/2015/198268

Guilherme, V.A., Ribeiro, L.N., Alcântara, A.C., Castro, S.R., Rodrigues da Silva, G.H., da Silva, C.G., Breitkreitz, M.C., Clemente-Napimoga, J., Macedo, C.G., Abdalla, H.B., Bonfante, R., Cereda, C.M., and de Paula, E. (2019). Improved efficacy of naproxen-loaded NLC for temporo mandibular joint administration. Scientific Reports, 9(1). https://doi.org/10.1038/s41598-019-47486-w

Harun-Or-Rashida, Abul, K.L., Md. Zakir, H., and Abu, S.S.R. (2009). Design and Formulation of Once Daily Naproxen Sustained Release Tablet Matrix from Methocel K 15M CR and Methocel K 100M CR. Iranian Journal of Pharmaceutical Sciences, 5(4):215-224.

Ibrahim, M.A., and Abou El-Ela, A.E. (2017). Optimized furosemide taste masked orally disintegrating tablets. Saudi Pharmaceutical Journal, 25(7):1055-1062. https://doi.org/10.1016/j.jsps.2017.04.002

Jeevanandham, S., Dhachinamoorthi, D., Chandra Sekhar, K.B., Muthukumaran, M., Sriram, N., and Joysaruby, J. (2010). Formulation and evaluation of naproxen sodium orodispersible tablets - A sublimation technique. Asian Journal of Pharmaceutics, 4(1):48. https://doi.org/10.4103/0973-8398.63985

Lavyna, G. and Rao, C.H.T. (2015). Atenolol and Glipizide bilayer FloatingTablets: Formulation and Evaluation. European Journal of Pharmaceutical and Medical Research, 2(7):211-219.

Law, S., Derry, S., and Moore, R.A. (2013). Sumatriptan plus naproxen for acute migraine attacks in adults. Cochrane Database of Systematic Reviews, (10). https://doi.org/10.1002/14651858.CD008541.pub2

Lundstedt, T., Seifert, E., Abramo, L., Thelin, B., Nyström, Å., Pettersen, J., and Bergman, R. (1998). Experimental design and optimization. Chemometrics and Intelligent Laboratory Systems, 42(1-2):3-40. https://doi.org/10.1016/S0169-7439(98)00065-3

Monteiro, L.M., Löbenberg, R., Cotrim, P.C., Barros de Araujo, G.L., and Bou-Chacra, N. (2017). Buparvaquone nano structured lipidcarrier:Development of an affordable delivery system for the treatment of Leishmaniases. BioMedResearch International, 1-11. https://doi.org/10.1155/2017/9781603

Montgomery, D.C. (1999). Experimental Design for Product and Process Design and Development. Journal of the Royal Statistical Society. Series D (The Statistician), 48(2):159-177. https://doi.org/10.1111/1467-9884.00179

Mostafa, M., Gardouh, A.R., Abogresha, N.M., and Gad, S. (2020). Factorial design, formulation, in vitro and in vivo evaluation of rapid orally disintegrating tablets prepared by sublimation technique using captopril as a model drug. Journal of Drug Delivery Science and Technology, 57:101635. https://doi.org/10.1016/j.jddst.2020.101635

Omar, S.M., Ibrahim, F., and Ismail, A. (2020). Formulation and evaluation of Cyclodextrin-based nanosponges of Griseofulvin as a pediatric oral liquid dosage form for enhancing bioavailability and masking bitter taste. Saudi Pharmaceutical Journal, 28(3):349-361. https://doi.org/10.1016/j.jsps.2020.01.016

Pathan, I.B., Shingare, P.R., and Kurumkar, P. (2013). Formulation design and optimization of novel mouth dissolving tablets for venlafaxine hydrochloride using sublimation technique. Journal of Pharmacy Research, 6(6):593-598. https://doi.org/10.1016/j.jopr.2013.04.054

Pawar. P., Chawla, A., and Mehta, R. (2013). Formulation and in vitro evaluation of Eudragit S-100coated naproxen matrix tablets for colon-targeted drugdelivery system. Journal of Advanced Pharmaceutical Technology&Research, 4(1):31. https://doi.org/10.4103/2231-4040.107498

Ramarao, C.T. and Laxmi, S.B. (2023). Floating Drug Delivery of Sustained Release Antidepressant Mirtazapine Tablets by Box-Behnken Design: Formulation and Optimization. Indian J of Pharmaceutical Education and Research, 57(4):1-10.

Ramarao, C.T., Bammidi, I., Banala, M., Balaga, K., Cheekati, P. and Busa, Y. (2023). Assessment and validation of emulgel-based salicylic acid formulation development for drug release and optimisation by statistical design. International Journal of Computational Biology and Drug Design, 15(6):463-479. https://doi.org/10.1504/IJCBDD.2023.134615

Ramarao, C.T., Vineeth, P., Bhanuchandar, P., Madhuri, M., Jayaram, P., Jyothi, M.P., Kumar, T.B., and Yugandhar, S. (2016). Drug delivery systems and biopharmaceutical consideration of drug products designs:areview. European Journal of Pharmaceutical and Medical Research, 3(3):146-154.

Ramarao, Ch.T. and Gunta, P. (2022). Statistically optimization and formulation development of bromofenac sodium ophthalmic drug delivery. Suranaree Journal of Science and Technology, 29(6):070060(1-10).

Rao, B.S., Vijayanratna, J., and Ramarao, C.T. (2016). Optimization of Matrix Tablets Containing AlfuzosinHcl Employing Hpmc K4 M. European Journal of Pharmaceutical and Medical Research, 3(9):529-533.

Reshma, K. and Rao, C.H.T. (2017). Formulation and Development of Telmisartan Tablets Employing Factorial Designs and Stability. Indo American Journal of Pharmaceutical Sciences, 4(7):2,029-2,035.

Saidman, E., Chattah, A.K., Aragón, L., Sancho, M., Camí, G., Garnero, C., and Longhi, M. (2019). Inclusion complexes of β-cyclodextrin and polymorphs of mebendazole: Physicochemical characterization. European Journal of Pharmaceutical Sciences, 127:330-338. https://doi.org/10.1016/j.ejps.2018.11.012

Sammour, O.A., Hammad, M.A., Megrab, N.A., and Zidan, A.S. (2006). Formulation and optimization of mouth dissolve tablets containing rofecoxib solid dispersion. AAPS PharmSciTech, 7(2). https://doi.org/10.1208/pt070255

Sharma, P., Chawla, A., and Pawar, P. (2013). Design, development, and optimization of polymeric based-colonic drug delivery system of Naproxen. The Scientific World Journal, 1-12. https://doi.org/10.1155/2013/654829

Singh, B., Kapil, R., Nandi, M., and Ahuja, N. (2011). Developing oral drugdeliverysystemsusing formulation by design: Vital precepts, retrospect and prospects. Expert Opinion on Drug Delivery, 8(10):1341-1360. https://doi.org/10.1517/17425247.2011.605120

Solaiman, A., Suliman, A.S., Shinde, S., Naz, S., and Elkordy, A.A. (2016). Application of general multi level factorial design with formulation of fast disintegrating tablets containing croscaremellose sodium and Disintequick MCC-25. International Journal of Pharmaceutics, 501(1-2):87-95. https://doi.org/10.1016/j.ijpharm.2016.01.065

Somireddy, M. and Ch, T. (2022). Statistically2LevelFactorial by Design Expert: In-vitro Design and Formulation of Levitiracetam Extended Release Tablets. Indian Journal of Pharmaceutical Education and Research, 56(4):1-8. https://doi.org/10.5530/ijper.56.4.180

Srinivasa R.B. and Vijayaratana, J. (2017). Sustained release matrix tablets of diclofenac sodium employing Kollidon Sr, Peg6000, lactose monohydrate, and EUDRAGIT S100 in colon target. Indian drugs. 54(10):38-43. https://doi.org/10.53879/id.54.10.10814

Taraka Ramarao, C., and Pavani, P. (2023). Atorvastatin calcium formulation development followed by pharmacokinetic with in vitro and in vivo correlation (IVIVC) with employing surplus and hydroxy propyl methyl cellulose with optimization. Egyptian Pharmaceutical Journal, 22(2):209-222. https://doi.org/10.4103/epj.epj_43_22

Tarakaramarao, C., Chowdary, K.P.R., and Rajeswararao, P. (2016). Formulation Development of Valsartan Tablets: Optimization by 23Factorial Design, in vitro and Pharmacokinetic Evaluation. World Journal of Pharmaceutical Research, 5(2):1,423-1,434.

Tarakaramarao, Ch., and Somireddy, M. (2022). In- vitro Design and Formulation of Levitiracetam Extended Release Tablets. Research Journal of Pharmacy and Technology, 15(8):3,681-3,684. https://doi.org/10.52711/0974-360X.2022.00617

Tarakaramarao, Ch., Chowdary, K.P.R., and Rajeswara Rao, P. (2020). In vitro and in vivo pharmacokinetic evaluation of valsartan tablets: Optimization by factorial design 23. IndianDrugs, 57(11):15-21.

Teja, S.P. and Damodharan, N. (2018). 23 Full Factorial Model for Particle Size Optimization of Methotrexate Loaded Chitosan Nanocarriers: A Design of Experiments (DoE) Approach. BioMedResearch International, 1-9. https://doi.org/10.1155/2018/7834159

ÜstündağOkur, N., Yavaşoğlu, A., and Karasulu, H.Y. (2014). Preparation and evaluation of microemulsion formulations of naproxen for dermal delivery. Chemical and Pharmaceutical Bulletin, 62(2):135-143. https://doi.org/10.1248/cpb.c13-00051

Vijaya R.J. and Srinivasa, R.B. (2018). Design and characterization of Alfuzosinhcl gastro retentive floating matrix tablets employing HPMC K 100m. Indiandrugs, 55(11):71-73. https://doi.org/10.53879/id.55.11.10741

Xu, H., Han, W., Wang, J., and Li, M. (2016). Network meta-analysis of migraine disorder treatment by NSAIDs and triptans. The Journal of Headache and Pain, 17(1):113. https://doi.org/10.1186/s10194-016-0703-0

Yang, X., Patel, S., Sheng, Y., Pal, D., and Mitra, A.K. (2014). Statistical design for formulation optimization of hydrocortisone butyrate-loaded plga nanoparticles. AAPS PharmSciTech, 15(3):569-587. https://doi.org/10.1208/s12249-014-0072-4

Downloads

Published

2024-02-05

How to Cite

Challa, T. R., & SaiKiranmai, P. (2024). DESIGN AND DEVELOPMENT OF ANTI-INFLAMMATORY DRUG NAPROXEN SOLID DISPERSIONS AND FORMULATIONS BY FACTORIAL DESIGN APPROACH: Naproxen Solid Dispersions and Formulations. Suranaree Journal of Science and Technology, 30(6), 070071(1–11). https://doi.org/10.55766/sujst-2023-06-e01216